ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026
A strategic pathway for the ethical development of AI tools in dementia care.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Artificial intelligence (AI) is rapidly entering dementia clinical practice, offering opportunities across the care continuum. However, cognitive decline creates a unique ethical challenge. This perspective article proposes a strategy to ensure the responsible development and deployment of AI tools for dementia. An interdisciplinary workgroup of the Alzheimer's Association Innovation Roundtable synthesized ethical frameworks, regulatory standards, and empirical evidence to generate expert consensus. The result is a six-step strategic pathway tailored to dementia care: establish ethical foundations, conduct stakeholder engagement, lead a co-design approach, conduct an impact assessment, establish iterative design and feedback loops, and provide education and digital literacy. A practical implementation checklist accompanies the framework. Because responsible progress requires both safety and timely innovation, ethical evaluation must balance the risks of premature deployment against those of harmful delay. Operationalizing ethics throughout the AI lifecycle can ensure that innovation advances autonomy, equity, and safety for people living with dementia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.